SCHEMBL23933923

SCHEMBL23933923

CCc1cc(NC)ccc1C(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.33
TP53 P04637 1/20 0.33
HSP90AA1 P07900 1/20 0.33
CYP3A4 P08684 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
HIF1A Q16665 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
KCNK2 O95069 1/20 0.33
KCNA5 P22460 1/20 0.33
KCNH2 Q12809 1/20 0.33
KCNB1 Q14721 1/20 0.33
SLC18A1 P54219 1/20 0.33
SLC18A2 Q05940 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18417805 0.83 TDP1 (0.38) ALDH1A1HPGDSMN1; SMN2TP53HSP90AA1
SCHEMBL27821688 0.79 GAA (0.53) ALDH1A1HPGDSMN1; SMN2TP53CYP3A4
SCHEMBL13856244 0.77 ALDH1A1 (0.37) ALDH1A1HPGDHSP90AA1CYP3A4ALOX15
SCHEMBL25937859 0.74 PTGS1 (0.51) ALDH1A1SMN1; SMN2TP53HSD17B10TDP1
SCHEMBL9735709 0.74 CYP1A2 (0.43) ALDH1A1SMN1; SMN2TSHRTDP1L3MBTL1
SCHEMBL13169883 0.74 ALDH1A1 (0.54) ALDH1A1HPGDHSP90AA1THRBTDP1
SCHEMBL31190191 0.74 TRPA1 (0.52) ALDH1A1SMN1; SMN2TDP1
SCHEMBL599002 0.74 TRPA1 (0.52) ALDH1A1SMN1; SMN2TDP1
SCHEMBL21351250 0.74 SLC18A1 (0.35) ALDH1A1HPGDSMN1; SMN2TP53HSP90AA1
SCHEMBL15850424 0.74 POLB (0.38) POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023130023-A1 INHIBITING MONOACYLGLYCEROL LIPASE (MAGL) PSY THERAPEUTICS, INC. (US) 2023-07-06 WO disclosed
EP-3086815-B1 SULFONAMIDE-CONTAINING LINKAGE SYSTEMS FOR DRUG CONJUGATES ZYMEWORKS INC (CA) 2022-02-09 EP disclosed
EP-3087091-B1 VAR2CSA-DRUG CONJUGATES ZYMEWORKS INC (CA) 2021-10-20 EP disclosed